Stephen Hoge net worth and biography

Stephen Hoge Biography and Net Worth

President of Moderna
Stephen Hoge serves as the President of Moderna and leads all Research & Development for the company. Since Moderna’s early days, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic areas. More recently, he has assumed responsibility for the company’s Clinical Development Office. He joined Moderna in late 2012 from McKinsey & Company, where he was a partner in the healthcare practice. Prior to McKinsey, Dr. Hoge was a resident physician in New York City.

He holds an M.D. with thesis from the University of California, San Francisco, and a B.S. in neuroscience from Amherst College.

Currently, Dr. Hoge also serves on the Board of Directors of Axcella Health, Inc., a publicly traded, clinical-stage biotechnology company.

What is Stephen Hoge's net worth?

The estimated net worth of Stephen Hoge is at least $192.25 million as of September 12th, 2022. Dr. Hoge owns 1,625,800 shares of Moderna stock worth more than $192,250,850 as of October 3rd. This net worth approximation does not reflect any other assets that Dr. Hoge may own. Additionally, Dr. Hoge receives an annual salary of $1,800,000.00 as President at Moderna. Learn More about Stephen Hoge's net worth.

How old is Stephen Hoge?

Dr. Hoge is currently 46 years old. There are 5 older executives and no younger executives at Moderna. The oldest executive at Moderna is Mr. David W. Meline, Chief Financial Officer, who is 65 years old. Learn More on Stephen Hoge's age.

What is Stephen Hoge's salary?

As the President of Moderna, Inc., Dr. Hoge earned a total compensation package of $7,803,432.00 in 2021. Dr. Hoge earned a salary of $684,808.00, stock awards of $3,000,000.00, options awards of $3,000,000.00, non-equity compensation of $819,000.00, and other compensation of $299,624.00.The highest earning executive at Moderna is Mr. Stephane Bancel, CEO & Director, who commands a salary of $3,160,000.00 per year. Learn More on Stephen Hoge's salary.

How do I contact Stephen Hoge?

The corporate mailing address for Dr. Hoge and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected] Learn More on Stephen Hoge's contact information.

Has Stephen Hoge been buying or selling shares of Moderna?

Stephen Hoge has not been actively trading shares of Moderna during the past quarter. Most recently, Stephen Hoge sold 5,000 shares of the business's stock in a transaction on Monday, September 12th. The shares were sold at an average price of $141.66, for a transaction totalling $708,300.00. Following the completion of the sale, the president now directly owns 1,625,800 shares of the company's stock, valued at $230,310,828. Learn More on Stephen Hoge's trading history.

Who are Moderna's active insiders?

Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (CEO), W. Cornwell (Director), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), Lorence Kim (CFO), Shannon Klinger (Insider), David Meline (CFO), Elizabeth Nabel (Director), Paul Sagan (Director), and Tal Zaks (Insider). Learn More on Moderna's active insiders.

Are insiders buying or selling shares of Moderna?

During the last year, insiders at the sold shares 155 times. They sold a total of 1,722,381 shares worth more than $326,440,036.17. The most recent insider tranaction occured on September, 28th when CEO Stephane Bancel sold 40,000 shares worth more than $4,922,400.00. Insiders at Moderna own 17.3 % of the company. Learn More about insider trades at Moderna.

Information on this page was last updated on 9/28/2022.

Stephen Hoge Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2022Sell5,000$141.66$708,300.001,625,800View SEC Filing Icon  
8/29/2022Sell1,119$135.81$151,971.391,625,800View SEC Filing Icon  
8/23/2022Sell5,000$141.70$708,500.001,624,509View SEC Filing Icon  
8/15/2022Sell5,000$172.85$864,250.001,624,509View SEC Filing Icon  
8/12/2022Sell5,000$172.68$863,400.001,624,509View SEC Filing Icon  
8/10/2022Sell244$173.66$42,373.041,624,509View SEC Filing Icon  
7/25/2022Sell10,000$162.75$1,627,500.001,624,231View SEC Filing Icon  
7/13/2022Sell5,000$168.88$844,400.001,624,231View SEC Filing Icon  
6/24/2022Sell5,000$143.98$719,900.001,624,231View SEC Filing Icon  
6/13/2022Sell10,000$123.00$1,230,000.001,624,231View SEC Filing Icon  
5/31/2022Sell8,430$145.02$1,222,518.601,624,231View SEC Filing Icon  
5/10/2022Sell234$133.71$31,288.141,622,820View SEC Filing Icon  
5/3/2022Sell10,000$141.93$1,419,300.001,622,532View SEC Filing Icon  
4/25/2022Sell20,000$143.22$2,864,400.001,622,532View SEC Filing Icon  
4/12/2022Sell5,000$159.00$795,000.001,622,532View SEC Filing Icon  
4/4/2022Sell20,000$177.27$3,545,400.001,622,532View SEC Filing Icon  
3/24/2022Sell5,000$175.52$877,600.00View SEC Filing Icon  
3/18/2022Sell7,541$171.67$1,294,563.47View SEC Filing Icon  
2/14/2022Sell20,000$157.71$3,154,200.00View SEC Filing Icon  
2/10/2022Sell894$158.89$142,047.66View SEC Filing Icon  
2/2/2022Sell10,000$170.89$1,708,900.00View SEC Filing Icon  
1/24/2022Sell20,000$150.67$3,013,400.00View SEC Filing Icon  
1/13/2022Sell15,000$219.56$3,293,400.00View SEC Filing Icon  
12/27/2021Sell5,000$243.10$1,215,500.00View SEC Filing Icon  
12/23/2021Sell15,000$247.30$3,709,500.00View SEC Filing Icon  
12/13/2021Sell20,000$257.01$5,140,200.00View SEC Filing Icon  
12/2/2021Sell10,000$301.29$3,012,900.00View SEC Filing Icon  
11/15/2021Sell15,000$231.01$3,465,150.00View SEC Filing Icon  
11/12/2021Sell5,000$225.86$1,129,300.00View SEC Filing Icon  
11/3/2021Sell10,000$350.00$3,500,000.00View SEC Filing Icon  
10/25/2021Sell20,000$331.80$6,636,000.00View SEC Filing Icon  
10/13/2021Sell15,000$314.90$4,723,500.00View SEC Filing Icon  
10/4/2021Sell20,000$307.54$6,150,800.00View SEC Filing Icon  
9/24/2021Sell5,000$448.04$2,240,200.00View SEC Filing Icon  
9/13/2021Sell20,000$447.41$8,948,200.001,614,597View SEC Filing Icon  
9/2/2021Sell10,000$393.13$3,931,300.001,619,597View SEC Filing Icon  
8/13/2021Sell15,000$405.00$6,075,000.001,614,597View SEC Filing Icon  
7/26/2021Sell5,000$351.99$1,759,950.005,000View SEC Filing Icon  
7/23/2021Sell15,000$335.13$5,026,950.001,614,597View SEC Filing Icon  
7/13/2021Sell15,000$238.87$3,583,050.001,614,597View SEC Filing Icon  
7/6/2021Sell10,000$229.62$2,296,200.001,619,597View SEC Filing Icon  
6/23/2021Sell15,000$216.20$3,243,000.001,614,597View SEC Filing Icon  
6/14/2021Sell20,000$213.32$4,266,400.001,614,597View SEC Filing Icon  
5/3/2021Sell20,000$183.66$3,673,200.00
4/23/2021Sell15,000$172.19$2,582,850.001,614,597View SEC Filing Icon  
4/13/2021Sell15,000$146.62$2,199,300.001,614,597View SEC Filing Icon  
4/5/2021Sell20,000$132.63$2,652,600.001,619,597View SEC Filing Icon  
3/24/2021Sell5,000$137.07$685,350.001,614,597View SEC Filing Icon  
3/15/2021Sell15,000$137.00$2,055,000.001,614,597View SEC Filing Icon  
3/12/2021Sell5,000$134.04$670,200.001,614,597View SEC Filing Icon  
2/23/2021Sell15,000$147.08$2,206,200.001,629,597View SEC Filing Icon  
2/12/2021Sell5,000$185.00$925,000.001,624,597View SEC Filing Icon  
2/3/2021Sell20,000$157.46$3,149,200.00
1/25/2021Sell20,000$140.97$2,819,400.001,649,597View SEC Filing Icon  
1/13/2021Sell15,000$123.70$1,855,500.001,644,597View SEC Filing Icon  
12/23/2020Sell10,000$124.14$1,241,400.001,734,597View SEC Filing Icon  
12/14/2020Sell20,000$163.63$3,272,600.001,744,597View SEC Filing Icon  
12/2/2020Sell10,000$138.57$1,385,700.001,744,597View SEC Filing Icon  
11/24/2020Sell5,000$97.93$489,650.001,754,597View SEC Filing Icon  
11/13/2020Sell20,000$86.82$1,736,400.00
10/26/2020Sell5,000$69.99$349,950.001,926,530View SEC Filing Icon  
10/23/2020Sell15,000$70.02$1,050,300.001,926,530View SEC Filing Icon  
10/12/2020Sell5,000$74.46$372,300.001,925,521View SEC Filing Icon  
10/5/2020Sell10,000$69.50$695,000.001,936,530View SEC Filing Icon  
10/2/2020Sell10,000$67.86$678,600.001,936,530View SEC Filing Icon  
9/24/2020Sell20,000$66.72$1,334,400.001,946,530View SEC Filing Icon  
9/14/2020Sell20,000$61.42$1,228,400.001,956,530View SEC Filing Icon  
9/2/2020Sell10,000$62.89$628,900.001,956,530View SEC Filing Icon  
8/24/2020Sell20,000$64.99$1,299,800.001,966,530View SEC Filing Icon  
8/13/2020Sell20,000$69.03$1,380,600.00
8/3/2020Sell20,000$74.89$1,497,800.001,976,530View SEC Filing Icon  
7/24/2020Sell20,000$78.86$1,577,200.001,986,530View SEC Filing Icon  
7/13/2020Sell10,000$69.92$699,200.001,986,530View SEC Filing Icon  
7/6/2020Sell10,000$58.48$584,800.001,986,540View SEC Filing Icon  
7/2/2020Sell10,000$59.94$599,400.001,986,540View SEC Filing Icon  
6/23/2020Sell5,000$63.69$318,450.001,983,531View SEC Filing Icon  
6/15/2020Sell10,000$63.32$633,200.00
5/26/2020Sell10,000$61.85$618,500.002,005,495View SEC Filing Icon  
5/12/2020Sell5,000$64.50$322,500.002,015,657View SEC Filing Icon  
4/23/2020Sell5,000$49.02$245,100.002,025,140View SEC Filing Icon  
3/23/2020Sell5,000$27.93$139,650.002,045,267View SEC Filing Icon  
1/23/2020Sell5,000$21.99$109,950.002,081,915View SEC Filing Icon  
1/13/2020Sell10,000$19.14$191,400.002,086,530View SEC Filing Icon  
See Full Table

Stephen Hoge Buying and Selling Activity at Moderna

This chart shows Stephen Hoge's buying and selling at Moderna by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Moderna Company Overview

Moderna logo
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $120.99
Low: $115.52
High: $122.40

50 Day Range

MA: $147.19
Low: $118.07
High: $194.18

2 Week Range

Now: $120.99
Low: $115.03
High: $376.65

Volume

3,793,808 shs

Average Volume

6,405,627 shs

Market Capitalization

$48.12 billion

P/E Ratio

3.69

Dividend Yield

N/A

Beta

1.7